Sorrell decision elicits commentary from legal experts, others


The legal community and other interested parties are parsing through the Supreme Court's recent decision in Sorrell v. IMS Health Inc., to determine what the short- and long-term ramifications are of greater First Amendment protection for marketing and expanded protection of data mining. Several unresolved questions stemming from the decision are whether the FDA's current regulation of "off-label" communication by drug companies is still valid and whether the government can continue to use privacy as a justification for marketing limits. Read more.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY